Molecular Diagnostics-Asia Pacific Market Status and Trend Report 2013-2023

SKU ID :MI-13750549 | Published Date: 04-Mar-2019 | No. of pages: 155
Table of Contents Chapter 1 Overview of Molecular Diagnostics 1.1 Definition of Molecular Diagnostics in This Report 1.2 Commercial Types of Molecular Diagnostics 1.2.1 PCR 1.2.2 DNA Sequencing 1.2.3 NGS 1.3 Downstream Application of Molecular Diagnostics 1.3.1 Infectious Disease (Hepatitis, HIV) 1.3.2 Oncology 1.3.3 Genetic Testing 1.4 Development History of Molecular Diagnostics 1.5 Market Status and Trend of Molecular Diagnostics 2013-2023 1.5.1 Asia Pacific Molecular Diagnostics Market Status and Trend 2013-2023 1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023 Chapter 2 Asia Pacific Market Status and Forecast by Regions 2.1 Market Status of Molecular Diagnostics in Asia Pacific 2013-2017 2.2 Consumption Market of Molecular Diagnostics in Asia Pacific by Regions 2.2.1 Consumption Volume of Molecular Diagnostics in Asia Pacific by Regions 2.2.2 Revenue of Molecular Diagnostics in Asia Pacific by Regions 2.3 Market Analysis of Molecular Diagnostics in Asia Pacific by Regions 2.3.1 Market Analysis of Molecular Diagnostics in China 2013-2017 2.3.2 Market Analysis of Molecular Diagnostics in Japan 2013-2017 2.3.3 Market Analysis of Molecular Diagnostics in Korea 2013-2017 2.3.4 Market Analysis of Molecular Diagnostics in India 2013-2017 2.3.5 Market Analysis of Molecular Diagnostics in Southeast Asia 2013-2017 2.3.6 Market Analysis of Molecular Diagnostics in Australia 2013-2017 2.4 Market Development Forecast of Molecular Diagnostics in Asia Pacific 2018-2023 2.4.1 Market Development Forecast of Molecular Diagnostics in Asia Pacific 2018-2023 2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2018-2023 Chapter 3 Asia Pacific Market Status and Forecast by Types 3.1 Whole Asia Pacific Market Status by Types 3.1.1 Consumption Volume of Molecular Diagnostics in Asia Pacific by Types 3.1.2 Revenue of Molecular Diagnostics in Asia Pacific by Types 3.2 Asia Pacific Market Status by Types in Major Countries 3.2.1 Market Status by Types in China 3.2.2 Market Status by Types in Japan 3.2.3 Market Status by Types in Korea 3.2.4 Market Status by Types in India 3.2.5 Market Status by Types in Southeast Asia 3.2.6 Market Status by Types in Australia 3.3 Market Forecast of Molecular Diagnostics in Asia Pacific by Types Chapter 4 Asia Pacific Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Molecular Diagnostics in Asia Pacific by Downstream Industry 4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries 4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in China 4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Japan 4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in Korea 4.2.4 Demand Volume of Molecular Diagnostics by Downstream Industry in India 4.2.5 Demand Volume of Molecular Diagnostics by Downstream Industry in Southeast Asia 4.2.6 Demand Volume of Molecular Diagnostics by Downstream Industry in Australia 4.3 Market Forecast of Molecular Diagnostics in Asia Pacific by Downstream Industry Chapter 5 Market Driving Factor Analysis of Molecular Diagnostics 5.1 Asia Pacific Economy Situation and Trend Overview 5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview Chapter 6 Molecular Diagnostics Market Competition Status by Major Players in Asia Pacific 6.1 Sales Volume of Molecular Diagnostics in Asia Pacific by Major Players 6.2 Revenue of Molecular Diagnostics in Asia Pacific by Major Players 6.3 Basic Information of Molecular Diagnostics by Major Players 6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players 6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Molecular Diagnostics Major Manufacturers Introduction and Market Data 7.1 ABBOTT LABORATORIES 7.1.1 Company profile 7.1.2 Representative Molecular Diagnostics Product 7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ABBOTT LABORATORIES 7.2 AGILENT TECHNOLOGIES 7.2.1 Company profile 7.2.2 Representative Molecular Diagnostics Product 7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES 7.3 BECTON, DICKINSON AND COMPANY 7.3.1 Company profile 7.3.2 Representative Molecular Diagnostics Product 7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BECTON, DICKINSON AND COMPANY 7.4 BIOMERIEUX 7.4.1 Company profile 7.4.2 Representative Molecular Diagnostics Product 7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BIOMERIEUX 7.5 DANAHER 7.5.1 Company profile 7.5.2 Representative Molecular Diagnostics Product 7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DANAHER 7.6 DIASORIN 7.6.1 Company profile 7.6.2 Representative Molecular Diagnostics Product 7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DIASORIN 7.7 GRIFOLS 7.7.1 Company profile 7.7.2 Representative Molecular Diagnostics Product 7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GRIFOLS 7.8 HOLOGIC 7.8.1 Company profile 7.8.2 Representative Molecular Diagnostics Product 7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of HOLOGIC 7.9 ILLUMINA 7.9.1 Company profile 7.9.2 Representative Molecular Diagnostics Product 7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ILLUMINA 7.10 QIAGEN 7.10.1 Company profile 7.10.2 Representative Molecular Diagnostics Product 7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN 7.11 ROCHE DIAGNOSTICS 7.11.1 Company profile 7.11.2 Representative Molecular Diagnostics Product 7.11.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ROCHE DIAGNOSTICS 7.12 SIEMENS 7.12.1 Company profile 7.12.2 Representative Molecular Diagnostics Product 7.12.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of SIEMENS 7.13 THERMO FISHER SCIENTIFIC 7.13.1 Company profile 7.13.2 Representative Molecular Diagnostics Product 7.13.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC Chapter 8 Upstream and Downstream Market Analysis of Molecular Diagnostics 8.1 Industry Chain of Molecular Diagnostics 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Molecular Diagnostics 9.1 Cost Structure Analysis of Molecular Diagnostics 9.2 Raw Materials Cost Analysis of Molecular Diagnostics 9.3 Labor Cost Analysis of Molecular Diagnostics 9.4 Manufacturing Expenses Analysis of Molecular Diagnostics Chapter 10 Marketing Status Analysis of Molecular Diagnostics 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference
List of Tables Table Advantage and Disadvantage of PCR Table Advantage and Disadvantage of DNA Sequencing Table Advantage and Disadvantage of NGS Table Consumption Volume of Molecular Diagnostics in Asia Pacific by Regions 2013-2017 Table Revenue of Molecular Diagnostics in Asia Pacific by Regions 2013-2017 Table Consumption Volume of Molecular Diagnostics in Asia Pacific by Regions 2018-2023 Table Revenue of Molecular Diagnostics in Asia Pacific by Regions 2018-2023 Table Consumption Volume of Molecular Diagnostics in Asia Pacific by Types 2013-2017 Table Revenue of Molecular Diagnostics in Asia Pacific by Types 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in China 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Japan 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Korea 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in India 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Southeast Asia 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Australia 2013-2017 Table Consumption Volume Forecast of Molecular Diagnostics in Asia Pacific by Types 2018-2023 Table Revenue Forecast of Molecular Diagnostics in Asia Pacific by Types 2018-2023 Table Demand Volume of Molecular Diagnostics in Asia Pacific by Downstream Industry 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in China 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Japan 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Korea 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in India 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Southeast Asia 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Australia 2013-2017 Table Demand Volume Forecast of Molecular Diagnostics in Asia Pacific by Downstream Industry 2018-2023 Table Sales Volume of Molecular Diagnostics in Asia Pacific by Major Players 2013-2017 Table Revenue of Molecular Diagnostics in Asia Pacific by Major Players 2013-2017 Table Headquarters Location and Established Time of Molecular Diagnostics Major Players Table Employees and Revenue Level of Molecular Diagnostics Major Players Table Representative Molecular Diagnostics Product One of ABBOTT LABORATORIES Table Representative Molecular Diagnostics Product Two of ABBOTT LABORATORIES Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ABBOTT LABORATORIES 2013-2017 Table Representative Molecular Diagnostics Product One of AGILENT TECHNOLOGIES Table Representative Molecular Diagnostics Product Two of AGILENT TECHNOLOGIES Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES 2013-2017 Table Representative Molecular Diagnostics Product One of BECTON, DICKINSON AND COMPANY Table Representative Molecular Diagnostics Product Two of BECTON, DICKINSON AND COMPANY Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BECTON, DICKINSON AND COMPANY 2013-2017 Table Representative Molecular Diagnostics Product One of BIOMERIEUX Table Representative Molecular Diagnostics Product Two of BIOMERIEUX Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BIOMERIEUX 2013-2017 Table Representative Molecular Diagnostics Product One of DANAHER Table Representative Molecular Diagnostics Product Two of DANAHER Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DANAHER 2013-2017 Table Representative Molecular Diagnostics Product One of DIASORIN Table Representative Molecular Diagnostics Product Two of DIASORIN Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DIASORIN 2013-2017 Table Representative Molecular Diagnostics Product One of GRIFOLS Table Representative Molecular Diagnostics Product Two of GRIFOLS Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GRIFOLS 2013-2017 Table Representative Molecular Diagnostics Product One of HOLOGIC Table Representative Molecular Diagnostics Product Two of HOLOGIC Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of HOLOGIC 2013-2017 Table Representative Molecular Diagnostics Product One of ILLUMINA Table Representative Molecular Diagnostics Product Two of ILLUMINA Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ILLUMINA 2013-2017 Table Representative Molecular Diagnostics Product One of QIAGEN Table Representative Molecular Diagnostics Product Two of QIAGEN Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN 2013-2017 Table Representative Molecular Diagnostics Product One of ROCHE DIAGNOSTICS Table Representative Molecular Diagnostics Product Two of ROCHE DIAGNOSTICS Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ROCHE DIAGNOSTICS 2013-2017 Table Representative Molecular Diagnostics Product One of SIEMENS Table Representative Molecular Diagnostics Product Two of SIEMENS Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of SIEMENS 2013-2017 Table Representative Molecular Diagnostics Product One of THERMO FISHER SCIENTIFIC Table Representative Molecular Diagnostics Product Two of THERMO FISHER SCIENTIFIC Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC 2013-2017
ABBOTT LABORATORIES AGILENT TECHNOLOGIES BECTON, DICKINSON AND COMPANY BIOMERIEUX DANAHER DIASORIN GRIFOLS HOLOGIC ILLUMINA QIAGEN ROCHE DIAGNOSTICS SIEMENS THERMO FISHER SCIENTIFIC
  • PRICE
  • $3480
    $5980

Our Clients